Skip to main content

Evidence > Risk Prediction

Although the literature on risk factors for pre-eclampsia is ever growing, PRE-EMPT sought to address the fact that very few of the informative data have been derived from populations of women who bear the greatest burden of experiencing complications of pre-eclampsia, namely women in less-developed countries.

With regards to risk prediction, particularly in less-resourced settings, there is a pressing need to identify women who are at increased risk for any placenta-derived antenatal complication, whether pre-eclampsia, gestational hypertension, or intrauterine growth restriction (IUGR).

Furthermore we realise that we cannot be certain that the pathways to pre-eclampsia are shared by women in more-developed countries and women in less-developed countries. It may be that screening biomarkers that are shown to be effective in more-developed countries in ongoing research will fail women in less-developed settings – this is a research priority for us.